Explore how evolving treatment strategies and biomarkers are transforming the management of HER2-positive breast cancer in clinical practice.
Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...
NICE has approved the first targeted treatment for chronic obstructive pulmonary disease (COPD), offering a new option to up ...
It seems there is no text provided for summarization. Please share the content you'd like summarized, and I'll be happy to help!
Advanced imaging, particularly PSMA PET scans, enhances detection of microscopic disease, allowing for more precise treatment ...
Low baseline ctDNA levels in advanced breast cancer patients predict better response to targeted therapy and longer ...
Novartis intends to submit ianalumab for regulatory approval globally in early 2026.
Targeted therapies are medicines to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted therapies work ...
Marginal zone lymphoma treatment evolves with promising CAR T-cell therapies, addressing unmet needs in aggressive cases and improving patient outcomes.
A University of Kentucky Markey Cancer Center study shows that a targeted form of radiation therapy can be safely delivered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results